King Bridge Investments Limited - Net Worth and Insider Trading
King Bridge Investments Limited Net Worth
The estimated net worth of King Bridge Investments Limited is at least $474 Million dollars as of 2024-06-16. King Bridge Investments Limited is the 2101 Beneficial owner of InnoCare Pharma Ltd and owns about 105,645,145 shares of InnoCare Pharma Ltd (HKSE:09969) stock worth over $474 Million. Details can be seen in King Bridge Investments Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that King Bridge Investments Limited has not made any transactions after 2024-04-12 and currently still holds the listed stock(s).
Transaction Summary of King Bridge Investments Limited
King Bridge Investments Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, King Bridge Investments Limited owns 1 companies in total, including InnoCare Pharma Ltd (HKSE:09969) .
Click here to see the complete history of King Bridge Investments Limited’s form 4 insider trades.
Insider Ownership Summary of King Bridge Investments Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:09969 | InnoCare Pharma Ltd | 2024-04-12 | 2101 Beneficial owner |
King Bridge Investments Limited Latest Holdings Summary
King Bridge Investments Limited currently owns a total of 1 stock. King Bridge Investments Limited owns 105,645,145 shares of InnoCare Pharma Ltd (HKSE:09969) as of April 12, 2024, with a value of $474 Million.
Latest Holdings of King Bridge Investments Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:09969 | InnoCare Pharma Ltd | 2024-04-12 | 105,645,145 | 4.49 | 474,346,701 |
Holding Weightings of King Bridge Investments Limited
King Bridge Investments Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, King Bridge Investments Limited has made a total of 7 transactions in InnoCare Pharma Ltd (HKSE:09969) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in InnoCare Pharma Ltd is the sale of 310,000 shares on April 12, 2024, which brought King Bridge Investments Limited around $2 Million.
Insider Trading History of King Bridge Investments Limited
- 1
King Bridge Investments Limited Trading Performance
GuruFocus tracks the stock performance after each of King Bridge Investments Limited's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by King Bridge Investments Limited is 7.12%. GuruFocus also compares King Bridge Investments Limited's trading performance to market benchmark return within the same time period. The performance of stocks bought by King Bridge Investments Limited within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how King Bridge Investments Limited's insider trading performs compared to the benchmark.
Performance of King Bridge Investments Limited
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.89 | | | | | |
| Relative Return to S&P 500(%) | 12.28 | | | | | |
King Bridge Investments Limited Ownership Network
King Bridge Investments Limited Owned Company Details
What does InnoCare Pharma Ltd do?
Who are the key executives at InnoCare Pharma Ltd?
King Bridge Investments Limited is the 2101 Beneficial owner of InnoCare Pharma Ltd. Other key executives at InnoCare Pharma Ltd include 2201 Interest of corporation controlled by you The Goldman Sachs Group, Inc. , Cui Jisong , and 2201 Interest of corporation controlled by you Pang Kee Chan Hebert .
InnoCare Pharma Ltd (HKSE:09969) Insider Trades Summary
Over the past 18 months, King Bridge Investments Limited made 5 insider transaction in InnoCare Pharma Ltd (HKSE:09969) with a net sale of 310,000. Other recent insider transactions involving InnoCare Pharma Ltd (HKSE:09969) include a net sale of 259,000 shares made by The Goldman Sachs Group, Inc. , a net sale of 6,000,000 shares made by Zhao Renbin , and a net sale of 5,684,000 shares made by Cui Jisong .
In summary, during the past 3 months, insiders sold 625,000 shares of InnoCare Pharma Ltd (HKSE:09969) in total and bought 316,000 shares, with a net sale of 309,000 shares. During the past 18 months, 18,625,000 shares of InnoCare Pharma Ltd (HKSE:09969) were sold and 316,000 shares were bought by its insiders, resulting in a net sale of 18,309,000 shares.
InnoCare Pharma Ltd (HKSE:09969)'s detailed insider trading history can be found in Insider Trading Tracker table.
InnoCare Pharma Ltd Insider Transactions
King Bridge Investments Limited Mailing Address
Above is the net worth, insider trading, and ownership report for King Bridge Investments Limited. Currently GuruFocus does not have mailing address information for King Bridge Investments Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
